[go: up one dir, main page]

SE0403005D0 - New use - Google Patents

New use

Info

Publication number
SE0403005D0
SE0403005D0 SE0403005A SE0403005A SE0403005D0 SE 0403005 D0 SE0403005 D0 SE 0403005D0 SE 0403005 A SE0403005 A SE 0403005A SE 0403005 A SE0403005 A SE 0403005A SE 0403005 D0 SE0403005 D0 SE 0403005D0
Authority
SE
Sweden
Prior art keywords
sub
new use
functional
dual
treatment
Prior art date
Application number
SE0403005A
Other languages
Swedish (sv)
Inventor
Maria Astin
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0403005A priority Critical patent/SE0403005D0/en
Publication of SE0403005D0 publication Critical patent/SE0403005D0/en
Priority to PCT/SE2005/001866 priority patent/WO2006062478A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/541—Non-condensed thiazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention relates to the use of dual NK<SUB>1</SUB>/NK<SUB>2</SUB> receptor antagonists for the treatment of functional gastrointestinal disorders, such as functional dyspepsia.
SE0403005A 2004-12-09 2004-12-09 New use SE0403005D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
SE0403005A SE0403005D0 (en) 2004-12-09 2004-12-09 New use
PCT/SE2005/001866 WO2006062478A1 (en) 2004-12-09 2005-12-07 Novel treatment of gastrointestinal disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0403005A SE0403005D0 (en) 2004-12-09 2004-12-09 New use

Publications (1)

Publication Number Publication Date
SE0403005D0 true SE0403005D0 (en) 2004-12-09

Family

ID=33550627

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0403005A SE0403005D0 (en) 2004-12-09 2004-12-09 New use

Country Status (2)

Country Link
SE (1) SE0403005D0 (en)
WO (1) WO2006062478A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CL2008003595A1 (en) 2007-12-03 2009-11-20 Takeda Pharmaceuticals Co Nitrogen heterocyclic compounds, tachykinin receptor antagonists; pharmaceutical agent comprising the compound; and use in the prophylaxis or treatment of a lower urinary tract disease, a gastrointestinal disease, or a disease of the central nervous system.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1097137A1 (en) * 1998-07-10 2001-05-09 AstraZeneca AB N-substituted naphthalene carboxamides as neurokinin-receptor antagonists
GB9922519D0 (en) * 1998-10-07 1999-11-24 Zeneca Ltd Compounds
GB9826941D0 (en) * 1998-12-09 1999-02-03 Zeneca Pharmaceuticals Compounds
JP2006516581A (en) * 2003-01-27 2006-07-06 グラクソ　グループ　リミテッド Use of chemical compounds to treat functional dyspepsia
TW200508221A (en) * 2003-06-13 2005-03-01 Astrazeneca Ab New azetidine compounds

Also Published As

Publication number Publication date
WO2006062478A1 (en) 2006-06-15

Similar Documents

Publication Publication Date Title
MY161834A (en) Substituted diazepan compounds as orexin receptor antagonists
DK2049529T3 (en) Substituted diazepan-orexin receptor antagonists
WO2007061763A3 (en) Indole orexin receptor antagonists
WO2003028641A3 (en) Mch receptor antagonists
ATE435206T1 (en) HETEROARYLSULFONYL STILBENES AS 5-HT2A ANTAGONISTS
EA201170624A1 (en) ISONICOTINAMIDE ANTAGONISTS OF OREXIN RECEPTORS
ATE469895T1 (en) CGRP RECEPTOR ANTAGONISTS
WO2008008517A3 (en) Bridged diazepan orexin receptor antagonists
WO2007126935A3 (en) Diazepan orexin receptor antagonists
CY1112969T1 (en) OREXIN RECEPTOR PYRIDYL Piperidine Antagonists
EA201100524A1 (en) AZAINDAZOLES AS ANTAGONISTS OF CCR1 RECEPTOR
JO2796B1 (en) Il-8 receptor antagonists
EA200970302A1 (en) TIOPHENPYRAZOLOPIRIMIDIN COMPOUNDS
UA106873C2 (en) COMPOUNDS OF SUBSTITUTED DIAZEPANES AS ANXAGONES OF OREXIN RECEPTORS
WO2006099268A3 (en) Cgrp receptor antagonists
WO2007025069A3 (en) Diazaspirodecane orexin receptor antagonists
GB0510143D0 (en) Novel compounds A1
MX2007002393A (en) Substituted indole compounds and their use as 5-ht6 receptor modulators.
MX2007011847A (en) Pyrimidindione derivatives as prokineticin 2 receptor antagonists.
WO2007019234A3 (en) Aminoethane sulfonamide orexin receptor antagonists
TW200800959A (en) Piperazine-piperidine antagonists and agonists of the 5-HT1a receptor
HRP20041014B1 (en) NEW COMPOUNDS AS OPIOID RECEPTOR MODULATORS
WO2006044449A3 (en) Cgrp receptor antagonists
ATE455111T1 (en) HISTAMINE RECEPTOR ANTAGONISTS CONTAINING AN AZEPINE CORE
SE0403005D0 (en) New use